中草药

夏枯草来源外泌体装载奥利司他通过调控脂代谢抑制肝癌细胞生长

PDF下载

中草药 | 药理与临床 2026,57(12): 4708-4720

收起

中草药 |药理与临床 2026 , 57 (12) : 4708 -4720

夏枯草来源外泌体装载奥利司他通过调控脂代谢抑制肝癌细胞生长

全屏

陶梦娟^1,2, 梁子成³, 方霞溢^1,2, 谭小宁², 曾普华^2,4

作者信息

通讯作者:

谭小宁

作者简介:

陶梦娟: 陶梦娟，女，硕士研究生，研究方向为中西医结合抗肿瘤研究。E-mail:13973195144@163.com

Prunella vulgaris-derived exosomes loading orlistat inhibit liver cancer cells growth by regulating lipid metabolism

TAO Mengjuan, LIANG Zicheng, FANG Xiayi, TAN Xiaoning, ZENG Puhua

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.12.016

文章导航

摘要

收起

目的探讨夏枯草来源外泌体装载奥利司他（Prunella vulgaris-derived exosomes loading orlistat，PVENs-Orl）对肝癌细胞脂代谢及恶性生物学行为的影响及其潜在机制。方法采用超速离心法提取PVENs，经透射电镜（transmission electron microscopy，TEM）及纳米颗粒追踪分析（nanoparticle tracking analysis，NTA）表征后，构建PVENs-Orl载药系统。通过CCK-8、克隆、划痕及Transwell实验评估PVENs-Orl对HepG2细胞增殖、迁移与侵袭的抑制作用。检测游离脂肪酸（free fatty acid，FFA）摄取、脂肪酸合成酶（fatty acid synthase，FASN）活性、三酰甘油（triglyceride，TG）含量、脂质过氧化指标及线粒体膜电位与形态。采用qRT-PCR检测脂代谢与铁死亡相关基因[酰基辅酶A合成酶长链家族成员4（acyl-CoA synthetase long-chain family member 4，ACSL4）、谷胱甘肽过氧化物酶4（glutathione peroxidase 4，GPX4）、溶质载体家族7成员11（solute carrier family 7 member 11，SLC7A11）、B细胞淋巴瘤-2相互作用蛋白3（Bcl-2 interacting protein 3，BNIP3L）、溶血磷脂酰胆碱酰基转移酶3（lysophosphatidylcholine acyltransferase 3，LPCAT3）、转铁蛋白受体（transferrin receptor，TFRC）]的表达。结果成功提取并表征了PVENs，构建的PVENs-Orl能被HepG2细胞有效内化。PVENs及PVENs-Orl呈剂量相关性抑制HepG2细胞的增殖、迁移与侵袭（P＜0.001）。在脂代谢表型上，PVENs-Orl能抑制FASN活性（P＜0.01），同时引起细胞内FFA与TG蓄积（P＜0.01）。PVENs-Orl显著提升细胞内活性氧（reactive oxygen species，ROS）和丙二醛（malondialdehyde，MDA）水平（P＜0.01、0.001），增加乳酸脱氢酶（lactate dehydrogenase，LDH）释放（P＜0.001）。PVENs-Orl显著诱导线粒体膜电位下降（P＜0.01），并引发线粒体功能障碍（P＜0.001）。分子机制上，PVENs-Orl上调脂质过氧化及铁死亡促进相关基因表达（P＜0.001），下调抗氧化及铁死亡抑制相关基因表达（P＜0.001）。结论 PVENs可有效递送奥利司他，通过抑制FASN活性破坏脂质稳态，诱导线粒体功能障碍和脂质过氧化，并协同调控铁死亡关键基因表达，从而抑制肝癌细胞生长，为基于天然外泌体的脂代谢靶向治疗提供了实验依据。

关键词

肝癌 / 夏枯草 / 外泌体 / 奥利司他 / 脂质代谢 / 铁死亡

Abstract

收起

Objective To investigate the effect and underlying mechanism of Prunella vulgaris-derived exosomes loaded with orlistat (PVENs-Orl) on lipid metabolism and malignant biological behaviors of hepatoma cells. Methods PVENs were extracted by ultracentrifugation. After characterization by transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA), a PVENs-Orl drug delivery system was constructed. The inhibitory effects of PVENs-Orl on the proliferation, migration and invasion of HepG2 cells were evaluated through CCK-8, cloning, scratch and Transwell assays. The free fatty acids (FFA) uptake, fatty acid synthase (FASN) activity, triglyceride (TG) content, lipid peroxidation indicators and mitochondrial membrane potential and morphology were detected. The expressions of genes related to lipid metabolism and ferroptosis [acyl-CoA synthetase long-chain family member 4 (ACSL4), glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), B-cell lymphoma-2 interacting protein 3 (BNIP3L), lysophosphatidylcholine acyltransferase 3 (LPCAT3), transferrin receptor (TFRC)] was detected by qRT-PCR. Results The PVENs were successfully extracted and characterized, and the constructed PVENs-Orl could be effectively internalized by HepG2 cells. PVENs and PVENs-Orl exhibited dose-dependent inhibition of the proliferation, migration and invasion of HepG2 cells (P < 0.001). In terms of lipid metabolism phenotype, PVENs-Orl could inhibit FASN activity (P < 0.01), and simultaneously cause intracellular accumulation of FFA and TG (P < 0.01). PVENs-Orl significantly increased the levels of intracellular reactive oxygen species (ROS) and malondialdehyde (MDA) (P < 0.01, 0.001), and increased the release of lactate dehydrogenase (LDH) (P < 0.001). PVENs-Orl significantly induced a decrease in mitochondrial membrane potential (P < 0.01) and triggered mitochondrial dysfunction (P < 0.001). At the molecular mechanism level, PVENs-Orl upregulated the expressions of genes related to lipid peroxidation and ferroptosis promotion (P < 0.001), and downregulated the expressions of genes related to antioxidant and ferroptosis inhibition (P < 0.001). Conclusion PVENs could effectively deliver orlistat, disrupt lipid homeostasis by inhibiting FASN activity, induce mitochondrial dysfunction and lipid peroxidation, and synergistically regulate the expressions of key genes involved in ferroptosis, thereby inhibiting the growth of liver cancer cells. This provides experimental evidence for targeted lipid metabolism therapy based on natural exosomes.

Key words

liver cancer / Prunella vulgaris L. / exosomes / orlistat / lipid metabolism / ferroptosis

引用本文

陶梦娟, 梁子成, 方霞溢, 谭小宁, 曾普华. 夏枯草来源外泌体装载奥利司他通过调控脂代谢抑制肝癌细胞生长. 中草药, 2026 , 57 (12) : 4708 -4720 . DOI: 10.7501/j.issn.0253-2670.2026.12.016

TAO Mengjuan, LIANG Zicheng, FANG Xiayi, TAN Xiaoning, ZENG Puhua. Prunella vulgaris-derived exosomes loading orlistat inhibit liver cancer cells growth by regulating lipid metabolism[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (12) : 4708 -4720 . DOI: 10.7501/j.issn.0253-2670.2026.12.016

基金

收起

国家自然科学基金面上项目 (82575174); 国家自然科学基金面上项目 (82074425); 湖南省重点研发计划项目 (2023SK2057); 湖南省自然科学基金资助项目 (2023JJ40403,2025JJ30038); 湖南省中医药管理局研究项目 (B2023089); 湖南中医药大学研究生创新项目 (2025CX188,2025CX199)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Kew M C. Hepatocellular carcinoma: Epidemiology and risk factors [J]. J Hepatocell Carcinoma, 2014, 1: 115-125.
Cheng Z J, Yang P H, Qu S P, et al. Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection [J]. HPB, 2015, 17(5): 422-427.
Chen R, Cheng Q, Owusu-Ansah K G, et al. Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma [J]. Am J Cancer Res, 2018, 8(7): 1297-1306.
Feng J, Bin J L, Liao X W, et al. The prognostic role of ACSL4 in postoperative adjuvant TACE-treated HCC: Implications for therapeutic response and mechanistic insights [J]. J Exp Clin Cancer Res, 2024, 43(1): 306.
曹媛媛, 刘珂如, 陈蕾. 肿瘤微环境异常脂质代谢对免疫系统影响的研究进展[J]. 中国医药导报, 2025, 22(17): 105-110.
Hao Q W, Li T, Zhang X, et al. Expression and roles of fatty acid synthase in hepatocellular carcinoma [J]. Oncol Rep, 2014, 32(6): 2471-2476.
Cui M, Xiao Z L, Wang Y, et al. Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway [J]. Cancer Res, 2015, 75(5): 846-857.
Wang H C, Zhou Y, Xu H W, et al. Therapeutic efficacy of FASN inhibition in preclinical models of HCC [J]. Hepatology, 2022, 76(4): 951-966.
Liang J N, Liao J Y, Chang R Z, et al. Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma [J]. Sci Immunol, 2025, 10(108): eado3485.
段伟静, 吕冬菊, 赵兴敏, 等. 降脂药奥利司他通过靶向脂代谢途径对肝细胞癌细胞HepG2增殖和凋亡的影响[J]. 河北医科大学学报, 2024, 45(3): 260-270.
Xu G X, Zhao Z Y, Wysham W Z, et al. Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer [J]. Front Oncol, 2023, 13: 1219923.
Alsunbul M, El-Masry T A, El Zahaby E I, et al. Potential protective effect of orlistat: A formulation of nanocrystals targeting inflammation, oxidative stress, and apoptosis in an experimental model of doxorubicin-induced cardiotoxicity [J]. Pharmaceutics, 2024, 16(11): 1356.
Salomon C, Das S, Erdbrügger U, et al. Extracellular vesicles and their emerging roles as cellular messengers in endocrinology: An endocrine society scientific statement [J]. Endocr Rev, 2022, 43(3): 441-468.
王智槟, 杨仁义, 张婧婷, 等. 石见穿外泌体通过诱导肝癌细胞铁死亡及凋亡抑制肿瘤生长[J]. 中草药, 2024, 55(19): 6622-6635.
Langellotto M D, Rassu G, Serri C, et al. Plant-derived extracellular vesicles: A synergetic combination of a drug delivery system and a source of natural bioactive compounds [J]. Drug Deliv Transl Res, 2025, 15(3): 831-845.
李梦琦, 石玉, 杨诗宇, 等. 夏枯草抗肿瘤活性成分及其作用机制研究进展[J]. 中国现代应用药学, 2024, 41(5): 716-726.
李飞燕, 王明刚, 毛德文, 等. 脂代谢重编程与原发性肝癌发生发展的关系[J]. 临床肝胆病杂志, 2024, 40(8): 1688-1692.
Cao L Q, Xie Y H, Fleishman J S, et al. Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies [J]. Cancer Lett, 2024, 597: 217061.
Zhou Y, Wang Z, Ren S, et al. Mechanism of action of protopanaxadiol ginsenosides on hepatocellular carcinoma and network pharmacological analysis [J]. Chin Herb Med, 2024, 16(4): 548-557.
Zhao B, Lin H J, Jiang X C, et al. Exosome-like nanoparticles derived from fruits, vegetables, and herbs: Innovative strategies of therapeutic and drug delivery [J]. Theranostics, 2024, 14(12): 4598-4621.
Zhang L, Li X M, Shi X H, et al. Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma [J]. Acta Pharmacol Sin, 2023, 44(3): 622-634.
Zheng J S, Sato M, Mishima E, et al. Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines [J]. Cell Death Dis, 2021, 12: 698.
Li C, Huang Q, Xiao J, et al. Preparation of Prunella vulgaris polysaccharide-zinc complex and its antiproliferative activity in HepG2 cells [J]. Int J Biol Macromol, 2016, 91: 671-679.
Pemble C W, Johnson L C, Kridel S J, et al. Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat [J]. Nat Struct Mol Biol, 2007, 14(8): 704-709.
Che L, Chi W N, Qiao Y, et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans [J]. Gut, 2020, 69(1): 177-186.
Cheng C, Hu J, Mannan R, et al. Targeting PIKfyve-driven lipid metabolism in pancreatic cancer [J]. Nature, 2025, 642(8068): 776-784.
Juan C A, Pérez de la Lastra J M, Plou F J, et al. The chemistry of reactive oxygen species (ROS) revisited: Outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies [J]. Int J Mol Sci, 2021, 22(9): 4642.
Ayala A, Muñoz M F, Argüelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal [J]. Oxid Med Cell Longev, 2014, 2014(1): 360438.
James A M, Cochemé H M, Murphy M P. Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing [J]. Mech Ageing Dev, 2005, 126(9): 982-986.
Mello T, Materozzi M, Galli A. PPARs and mitochondrial metabolism: From NAFLD to HCC [J]. PPAR Res, 2016, 2016(1): 7403230.
Ademowo O S, Dias H K I, Burton D G A, et al. Lipid (per) oxidation in mitochondria: An emerging target in the ageing process? [J]. Biogerontology, 2017, 18(6): 859-879.
Gao G, Shi Y, Deng H X, et al. Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson’s disease models [J]. Nat Commun, 2025, 16: 1982.
Yan B, Ai Y W, Sun Q, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1[J]. Mol Cell, 2021, 81(2): 355-369.e10.
Dixon S J, Lemberg K M, Lamprecht M R, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death [J]. Cell, 2012, 149(5): 1060-1072.
Cui J T, Wang Y K, Tian X T, et al. LPCAT3 is transcriptionally regulated by YAP/ZEB/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity [J]. Antioxid Redox Signal, 2023, 39(7/8/9): 491-511.
Ma H T, Huang Y T, Tian W R, et al. Endothelial transferrin receptor 1 contributes to thrombogenesis through cascade ferroptosis [J]. Redox Biol, 2024, 70: 103041.
Li Y, Zheng W Q, Lu Y Y, et al. BNIP3L/NIX-mediated mitophagy: Molecular mechanisms and implications for human disease [J]. Cell Death Dis, 2022, 13: 14.
Liu Y, Wan Y C, Jiang Y, et al. GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment [J]. Biochim Biophys Acta BBA Rev Cancer, 2023, 1878(3): 188890.

2026年第57卷第12期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.12.016

接收时间：2026-01-24
首发时间：2026-09-09

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2026-01-24

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.12.016

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT